Classification of Female Sexual Disorders
The classification of female sexual disorders has undergone several
revisions and continues to evolve as knowledge expands. Several useful
classification systems have been created, but no one system stands as the
hard-and-fast rule or gold standard. The following section discusses two of
the most widely known and used classifications.
DSM-IV Classification
The American Psychiatric Association’s DSM-IV: Diagnostic and Statistical
Manual, 4th edition, published in 1994, as well as the World Health
Organization’s International Statistical Classification of Diseases and
Related Health Problems-10 (ICD-10), published in 1992, contains a
classification system for female sexual disorders that is based on the
Masters and Johnson and Kaplan linear model of the female sexual
response.(1,2) The DSM-IV, which focuses on psychiatric disorders, defines a
female sexual disorder as a “disturbance in sexual desire and in the psychophysiological changes that characterize the sexual response cycle and
cause marked distress and interpersonal difficulty.” This classification
system has increasingly come under scrutiny and criticism, not the least of
which is because it focuses only on the psychiatric component of sexual
disorders.(3,4)
The DSM-IV categorizes female sexual disorders as follows:
- Sexual pain disorders
a. Dyspareunia
b.
Vaginismus
- Sexual dysfunction due to a general medical condition
- Sexual dysfunction not otherwise specified
The psychiatric diagnostic manual also provides subtypes to assist in
diagnosis and treatment of sexual disorders: whether the disorder is
lifelong or acquired, generalized or situational, and due to psychological
factors or combined psychological/medical factors.
American Foundation for Urologic Disease Consensus-Based Classification
of Female Sexual Dysfunction (CCFSD)
In 1999, an international multidisciplinary panel of 19 experts in female
sexual disorders was convened by the Sexual Function Health Council of the
American Foundation for Urologic Disease to evaluate and revise the existing
definitions for female sexual disorders from the DSM-IV and the ICD-10 in an
attempt to provide a well-defined, broadly accepted diagnostic framework for
clinical research and the treatment of female sexual problems.(5) The
conference was supported by educational grants from several pharmaceutical
companies. ( Affiliated Research Centers, Eli Lilly/ICOS Pharmaceuticals,
Pentech Pharmaceuticals, Pfizer Inc., Procter & Gamble Pharmaceuticals,
Inc., Schering-Plough, Solvay Pharmaceuticals, TAP Pharmaceuticals, and
Zonagen.)
HealthyPlace.com Audio
Integrated Approaches to Female Sexual Dysfunction
Medications and therapies that work for female sexual dysfunction.
Cynthia M. Watson, MD, Clinical Faculty Instructor,
Department of Family Medicine, UCLA School of Medicine. From the
2002 Women's Sexual Health Conference.
Listen with
Real Player. |
|
|
Like previous classifications, the Consensus-Based Classification of
Female Sexual Dysfunction (CCFSD) is based on the Masters and Johnson and
Kaplan linear model of the female sexual response, which is problematic.
However, the CCFSD classification represents an advance over the older
systems because it incorporates both psychogenic and organic causes of
desire, arousal, orgasm, and sexual pain disorders (see Table 7). The
diagnostic system also has a “personal distress” criterion, indicating that
a condition is considered a disorder only if a woman is distressed by it.
The four general categories from the DSM-IV and ICD-10 classifications
were used to structure the CCFSD system, with definitions for diagnoses as
described as follows.
- Sexual desire disorders are divided into two types. Hypoactive
sexual desire disorder is the persistent or recurrent deficiency (or
absence) of sexual fantasies/thoughts, and/or desire for or receptivity
to sexual activity, which causes personal distress. Sexual aversion
disorder is the persistent or recurrent phobic aversion to and avoidance
of sexual contact with a sexual partner, which causes personal distress.
- Sexual arousal disorder is the persistent or recurrent inability to
attain or maintain sufficient sexual excitement, causing personal
distress, which may be expressed as a lack of subjective excitement, or
genital (lubrication/swelling) or other somatic responses.
- Orgasmic disorder is the persistent or recurrent difficulty, delay
in, or absence of attaining orgasm following sufficient sexual
stimulation and arousal, which causes personal distress.
- Sexual pain disorders are also divided into three categories:
Dyspareunia is the recurrent or persistent genital pain associated with
sexual intercourse. Vaginismus is the recurrent or persistent
involuntary spasm of the musculature of the outer third of the vagina
that interferes with vaginal penetration, which causes personal
distress. Non-coital sexual pain disorder is recurrent or persistent
genital pain induced by non-coital sexual stimulation.
Disorders are further subtyped according to medical history, laboratory
tests, and physical examination as lifelong versus acquired, generalized
versus situational, and of organic, psychogenic, mixed, or unknown origin.
Next:: Diagnosing and Treating
Female Sexual Disorders
RESOURCES:
- American Psychiatric Association. DSM IV: Diagnostic and Statistical
Manual for Mental Disorders, 4th ed. Washington, DC: American
Psychiatric Press; 1994.
- World Health Organization. ICD 10: International Statistical
Classification of Diseases and Related Health Problems. Geneva: World
Health Organization; 1992.
- Sugrue DP, Whipple B.
The consensus-based classification of female sexual dysfunction: barriers to
universal acceptance. J Sex Marital Ther 2001;27:221-226.
- Working Group on A New View of Women’s Sexual Problems. A new view
of women’s sexual problems. Electronic Journal of Human Sexuality
2000;3. Available at www.ejhs.org/volume 3/newview.htm. Accessed
3/21/05.
- Basson R, Berman J,
Burnett A, et al. Report of the International Consensus Development
Conference on female sexual dysfunction: definitions and classifications. J
Urol 2000;163:888-893.
Last updated: 10/05
top ~ next ~
send page
to friend
|